NAUT CIK: 1808805

Nautilus Biotechnology, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−39.2
FY22:
−45.8
FY23:
−51.7
FY24:
−59.1
FY25:
−50.7
Change from FY21 to FY25
millions USD
FY21:
−139
FY22:
−25.7
FY23:
−43.7
FY24:
66.3
FY25:
35.2
Change from FY21 to FY25
millions USD
FY21:
327
FY22:
0.56
FY23:
0.37
FY24:
1.14
FY25:
0.21
millions USD
FY21:
149
FY22:
−71.0
FY23:
−95.1
FY24:
8.25
FY25:
−15.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−41.5
FY22:
−48.1
FY23:
−54.2
FY24:
−61.3
FY25:
−52.0

All amounts in millions USD Data source:SEC EDGAR